These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36930883)
1. Effect of the structural modification of Candesartan with Zinc on hypertension and left ventricular hypertrophy. Martinez VR; Martins Lima A; Stergiopulos N; Velez Rueda JO; Islas MS; Griera M; Calleros L; Rodriguez Puyol M; Jaquenod de Giusti C; Portiansky EL; Ferrer EG; De Giusti V; Williams PAM Eur J Pharmacol; 2023 May; 946():175654. PubMed ID: 36930883 [TBL] [Abstract][Full Text] [Related]
2. Candesartan cilexetil attenuated cardiac remodeling by improving expression and function of mitofusin 2 in SHR. Wang Z; Niu Q; Peng X; Li M; Liu K; Liu Y; Liu J; Jin F; Li X; Wei Y Int J Cardiol; 2016 Jul; 214():348-57. PubMed ID: 27085127 [TBL] [Abstract][Full Text] [Related]
3. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR. Raasch W; Jöhren O; Schwartz S; Gieselberg A; Dominiak P J Hypertens; 2004 Mar; 22(3):611-8. PubMed ID: 15076168 [TBL] [Abstract][Full Text] [Related]
4. AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan. Zhao Y; Ma R; Yu X; Li N; Zhao X; Yu J J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):450-459. PubMed ID: 31023080 [TBL] [Abstract][Full Text] [Related]
5. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats. Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077 [TBL] [Abstract][Full Text] [Related]
6. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats. Paull JR; Widdop RE J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847 [TBL] [Abstract][Full Text] [Related]
7. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats. Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211 [TBL] [Abstract][Full Text] [Related]
8. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats. Mizuno K; Niimura S; Katoh K; Fukuchi S Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052 [TBL] [Abstract][Full Text] [Related]
11. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. Dahlöf B J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480 [TBL] [Abstract][Full Text] [Related]
12. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats. Pu Q; Larouche I; Schiffrin EL Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats. Shinzato T; Ohya Y; Nakamoto M; Ishida A; Takishita S Hypertens Res; 2007 Sep; 30(9):863-73. PubMed ID: 18037780 [TBL] [Abstract][Full Text] [Related]
14. Candesartan cilexetil improves left ventricular function, left ventricular hypertrophy, and endothelial function in patients with hypertensive heart disease. Isobe N; Taniguchi K; Oshima S; Ono Z; Adachi H; Toyama T; Naito S; Hoshizaki H; Kamiyama H Circ J; 2002 Nov; 66(11):993-9. PubMed ID: 12419928 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blockade prevents diastolic heart failure through modulation of Ca(2+) regulatory proteins and extracellular matrix. Sakata Y; Yamamoto K; Mano T; Nishikawa N; Yoshida J; Nakayama H; Otsu K; Suzuki K; Tada M; Hori M; Miwa T; Masuyama T J Hypertens; 2003 Sep; 21(9):1737-45. PubMed ID: 12923407 [TBL] [Abstract][Full Text] [Related]
16. Gallic acid attenuates calcium calmodulin-dependent kinase II-induced apoptosis in spontaneously hypertensive rats. Jin L; Piao ZH; Liu CP; Sun S; Liu B; Kim GR; Choi SY; Ryu Y; Kee HJ; Jeong MH J Cell Mol Med; 2018 Mar; 22(3):1517-1526. PubMed ID: 29266709 [TBL] [Abstract][Full Text] [Related]
17. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats. Mizuno K; Tani M; Hashimoto S; Niimura S; Sanada H; Watanabe H; Ohtsuki M; Fukuchi S Life Sci; 1992; 51(5):367-74. PubMed ID: 1385640 [TBL] [Abstract][Full Text] [Related]
18. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype. Kim S; Iwao H J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120 [TBL] [Abstract][Full Text] [Related]
19. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats. Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855 [TBL] [Abstract][Full Text] [Related]
20. Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension. Mitsunami K; Inoue S; Maeda K; Endoh S; Takahashi M; Okada M; Sugihara H; Kinoshita M Cardiovasc Drugs Ther; 1998 Oct; 12(5):469-74. PubMed ID: 9926278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]